0000950123-21-002050.txt : 20210216 0000950123-21-002050.hdr.sgml : 20210216 20210212182114 ACCESSION NUMBER: 0000950123-21-002050 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20201231 FILED AS OF DATE: 20210216 DATE AS OF CHANGE: 20210212 EFFECTIVENESS DATE: 20210216 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Column Group LLC CENTRAL INDEX KEY: 0001833486 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-20797 FILM NUMBER: 21630659 BUSINESS ADDRESS: STREET 1: LETTERMAN DRIVE, BUILDING D, SUITE M-900 CITY: SAN FRANCISCO STATE: CA ZIP: 94129 BUSINESS PHONE: 415-865-2050 MAIL ADDRESS: STREET 1: LETTERMAN DRIVE, BUILDING D, SUITE M-900 CITY: SAN FRANCISCO STATE: CA ZIP: 94129 13F-HR 1 primary_doc.xml 13F-HR LIVE 0001833486 XXXXXXXX 12-31-2020 12-31-2020 false Column Group LLC

LETTERMAN DRIVE, BUILDING D, SUITE M-900 San Francisco CA 94129

13F HOLDINGS REPORT 028-20797 Y Certain shares holdings that are reported on this 13F were previously reported on a 13F filed by Peter Svennilson (CIK: 0001606074) (File No. 028-16412) James Evangelista (415) 865-2050 /s/ James Evangelista San Francisco CA 02-12-2021 0 7 1102466 false INFORMATION TABLE 2 3176.xml INFORMATION TABLE FOR FORM 13F Constellation Pharmaceuticals Inc. COM 210373106 75647 2626631 SH SOLE 0 2626631 0 Gritstone Oncology Inc COM 39868T105 3426 869493 SH SOLE 0 869493 0 Revolution Medicines Inc COM 76155X100 141742 3580252 SH SOLE 0 3580252 0 RAPT Therapeutics Inc COM 75382E109 76742 3885679 SH SOLE 0 3885679 0 ORIC Pharmaceuticals Inc. COM 68622P109 161403 4768181 SH SOLE 0 4768181 0 NGM Biopharmaceuticals Inc COM 62921N105 466502 15396116 SH SOLE 0 15396116 0 Nurix Therapeutics Inc COM 67080M103 177004 5383333 SH SOLE 0 5383333 0